Skip to main content
. 2009 Jul 8;83(18):9370–9387. doi: 10.1128/JVI.02076-08

TABLE 1.

Oligonucleotides used in this study

No. Name Sequence (5′-3′)a
1 PV-3B-3C-Glu-Gly-for CGG ACA GCA AAG GTA GAA GGA CCA GGG TTC G
2 PV-3B-3C-Glu-Gly-rev CGA ACC CTG GTC CTT CTA CCT TTG CTG TCC G
3 3B-3C-QGtoGG-f CGG ACA GCA AAG GTA GGA GGA CCA GGG TTC GAT TAC
4 3B-3C-QGtoGG-r GTA ATC GAA CCC TGG TCC TCC TAC CTT TGC TGT CCG
5 pRLuc-BglII-r CGC AGA TCT CCA CTT CTT TGC CA
6 pMoRA-SnaBI-f TTA TGT ACG TAC CAC CAGGAGCTC CAG TGC CCG AG
7 pRLucRA-3B-Y3F-f GGA CAC CAG GGA GCA TTC ACT GGT TTA CC
8 pRLucRA-3B-Y3F-r GGT AAA CCA GTG AAT GCT CCC TGG TGT CC
9 pLP-Rev-TRE BamHI 3CD for GCG GGA TCC GCC ACC ATG GGA CCA GGG TTC GAT TAC
10 pLp-RevTRe-3CD-SphI-rev ACG CGC ATG CTT ACT AAA ATG AGT C
11 3A-SacII-f GCG GAA TTC CCG CGG TGG AGG ACC ACT CCA GTA T
12 3D seq 1085 Rev CTC CCA TGT GAC TGT TTC AAA TG
13 3C 1 seq GGA CCA GGG TTC GAT TAC G
14 3D seq 138 Rev GTC TGT CTT AAG CCT GGG ATC G
15 3D seq 100 GTT TGA AGG GGT GAA GGA A
a

Restriction sites are shown in boldface; codons containing nucleotide changes are italicized.